Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.

CSE:SONA - Post by User

Sona Nanotech Inc > Sona mentioned in the Rockefeller Foundation report

<< Previous

Bullboard Posts

Next >>

Comment by TheeRookon Jul 17, 2020 1:21pm

189 Views

Post# 31282082

RE:RE:Sona mentioned in the Rockefeller Foundation report

The FDA will be asking the same questions.
3 AG tests all aroung 85% with better sensistivity and SONA - 96%.

FDA could be requesting more Field data samples after the 30 they finish later this month.
If FDA testing does not match.

If FDA Match . Approved GNR work.

Findingmoney wrote: I noticed in the Rockefeller report the company PCL from Korea claimed 100% Sensitivity, yet it has only 85% accuracy.

https://www.rockefellerfoundation.org/wp-content/uploads/2020/07/National-Covid-19-Testing-and-Tracing-Action-Plan-Full-Update-Report.pdf

https://www.asiatechdaily.com/korea-firm-covid-19-testing-kit/